Leios Therapeutics
PrivateLast Round
Strategic
Aug 30, 2026
Total Funding Raised
$2.47M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Leios Therapeutics is a clinical-stage biotechnology company that develops innovative injectable therapies for aesthetic indications, including focal fat reduction and body contouring.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Fashion & Beauty, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Leios Therapeutics Comparables
Compare Leios Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sagesse Bio, Inc. | 86% | |
| AMI Pharm Co., Ltd. | 85% | |
| Raziel Therapeutics | 83% |
Leios Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Aug 30, 2026 | ||||
| Strategic | Jan 26, 2026 | ||||
| Series B | Aug 23, 2021 | ||||
| VC Round | Apr 19, 2018 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 30, 2026
China Medical System Holdings Limited participated in the round.
- Jan 26, 2026
BNC Korea Co. Ltd participated in the round.
Recent news
Latest coverage and updates
- partners_withSep 14, 2026
Leios Therapeutics partnered with Bnc Korea on Jul 1st '26.
- partners_withAug 31, 2026
Leios Therapeutics partnered with CMS International Development And Management Limited on Aug 30th '26.
Leios Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Leios Therapeutics's valuation, stock price, and market status.
Is Leios Therapeutics a public or private company?
Leios Therapeutics is a private company.
What is the current stock price of Leios Therapeutics?
Leios Therapeutics is a private company, so its shares have no public market price. Caplight tracks Leios Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Leios Therapeutics worth (valuation)?
Valuation information for Leios Therapeutics is not publicly available.
Can I buy Leios Therapeutics stock?
Leios Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Leios Therapeutics's last funding round?
Leios Therapeutics's most recent funding round was Strategic on August 30, 2026.
Who are the main investors in Leios Therapeutics?
Investor information for Leios Therapeutics is not publicly disclosed.
Will Leios Therapeutics IPO soon?
No public IPO plans have been announced for Leios Therapeutics.
How can I track Leios Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Leios Therapeutics's shares on secondary markets.